Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Hematology-Oncology

Malignant Mesothelioma Conference 2012

Potential New Treatments for Mesothelioma

Mary Hesdorffer, NP and Executive Director of the Mesothelioma Applied Research Foundation, discusses the latest advances in treatment options for mesothelioma. Results from early-stage clinical trials show a future of promising treatments, including the...

Reuters Health • The Doctor's Channel Daily Newscast

Azacitidine Before Stem-Cell Transplant for MDS Improves Survival

NEW YORK (Reuters Health) – Patients with myelodysplastic syndrome (MDS) who are treated with azacitidine before allogeneic stem-cell transplantation fare as well as patients receiving standard pre-transplant induction chemotherapy, according to a...

Reuters Health • The Doctor's Channel Daily Newscast

Best Antithymocyte Globulin Dose Defined Before Transplant for Hematologic Disease

NEW YORK (Reuters Health) – Reduced-intensity conditioning that includes two daily 2.5-mg/kg doses of antithymocyte globulin before allogeneic stem-cell transplantation for hematologic malignancy significantly reduces graft-versus-host disease (GvHD)...